AXS Investments’s Novo Nordisk NVO Stock Holding History

AXS Investments’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$288K	Hold	6,000	–	–	0.08%	104
2026 Q1	$221K	Hold	6,000	–	–	0.09%	116
2025 Q4	$305K	Hold	6,000	–	–	0.11%	118
2025 Q3	$333K	Hold	6,000	–	–	0.1%	111
2025 Q2	$414K	Hold	6,000	–	–	0.17%	119
2025 Q1	$417K	Hold	6,000	–	–	0.12%	186
2024 Q4	$516K	Hold	6,000	–	–	0.14%	188
2024 Q3	$714K	Hold	6,000	–	–	0.19%	185
2024 Q2	$856K	Sell	6,000 -6,000	-50%	-$795K	0.24%	174
2024 Q1	$1.54M	Buy	12,000 +1,800	+18%	+$214K	0.37%	85
2023 Q4	$1.06M	Buy	+10,200	New	+$1.01M	0.25%	154

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AXS Investments's NVO Position: Q2 2026 in Review

AXS Investments held its Novo Nordisk (NVO) position steady in Q2 2026 at 6,000 shares worth $288K. The position accounts for 0.08% of the portfolio, ranked #104.

AXS Investments first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.54M in Q1 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

AXS Investments held 6,000 shares of Novo Nordisk worth $288K as of Q2 2026.
AXS Investments left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.08% of AXS Investments's portfolio in Q2 2026, its #104 holding.
AXS Investments first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
AXS Investments's Novo Nordisk position peaked at $1.54M in Q1 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.